Viewing Study NCT03853369


Ignite Creation Date: 2025-12-24 @ 11:00 PM
Ignite Modification Date: 2026-01-02 @ 1:42 PM
Study NCT ID: NCT03853369
Status: UNKNOWN
Last Update Posted: 2019-03-14
First Post: 2019-02-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Post-marketing Registration Study of Nifekalant Hydrochloride (NIF) Injection
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module